News » Visby Medical Appoints Industry Veteran Thomas Prescott as Chairman of the Board

10/28/2021Press Release

Visby Medical Appoints Industry Veteran Thomas Prescott as Chairman of the Board

Thomas Prescott, former president and chief executive officer (CEO) of Align Technology and Cardiac Pathways, will join as the company’s new chairman of the board.

Visby Medical Appoints Industry Veteran Thomas Prescott as Chairman of the Board

SAN JOSE, CA, October 28, 2021 – Visby Medical™, a leading medical diagnostic company, today announced Thomas Prescott, former president and chief executive officer (CEO) of Align Technology and Cardiac Pathways, will join as the company’s new chairman of the board. In his new role, Prescott will lead the Board of Directors and provide strategic counsel on critical growth initiatives for the company.

“I am excited to welcome Tom to the Visby team,” said Visby Medical Founder and CEO Adam de la Zerda. “With decades of experience in multiple leadership positions at innovative medical technology companies, Tom is well-positioned as a very valuable resource for Visby and will help guide our growth. We are very pleased to have him on board.”

Prescott previously served for 13 years as president, CEO and director of Align Technology, a global medical device company and creator of Invisalign, transforming the company from a new public start up to a market leader that established a new category of clear aligner therapy and digital dentistry. He continued to serve as a director of Align until May 2021. Prior to that, he served as president, CEO and director of Cardiac Pathways and held various executive and general management roles at Nellcor Puritan Bennett and GE Medical Systems. Prescott also serves as director and chairman at Earlens Corporation, a board member for The Navy SEAL Foundation, and a trustee at The Naval Postgraduate School Foundation.

“I’m honored to take on this role with an innovative company with proven success delivering the world’s first instrument-free, single-use PCR platform that accurately and rapidly tests for serious infections,” Prescott said. “These advances will be critical in changing the way people are diagnosed and treated for serious infections, and I look forward to working closely with the board to ensure Visby Medical makes a positive impact for all stakeholders.”

Prescott earned his master’s degree from Kellogg Graduate School of Management at Northwestern University and his bachelor’s degree in Civil Engineering from Arizona State University. He is an avid investor, and supports innovation and entrepreneurship at his alma mater, The Fulton School of Engineering at Arizona State University.

About Visby Medical™

Visby Medical is a diagnostics company that is transforming the order of diagnosis and treatment for infectious diseases. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests

Read more articles & insights

12/01/2023Viewpoint

Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).

Read More
Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

11/18/2023Viewpoint

A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

In the setting of a global pandemic, the specter of SARS-CoV-2 infection has understandably dominated the differential diagnosis for respiratory symptoms. However, it is crucial to remember that other respiratory pathogens continue to circulate, potentially leading to varied clinical presentations in patients who share the same exposure or living environment.

Read More
A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

05/11/2023Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

03/14/2023Press Release

Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.

Read More
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women